|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Supportive care, Treatment
|
|
|
|
Approved-not yet active
|
|
|
|
35 to 90
|
|
|
|
Other, Pharmaceutical / Industry
|
|
|
|
047838 NCT00805701
|
|
|
|
|
|
|
|
Last Modified: 8/9/2007  First Published: 10/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 to 70
|
|
|
|
Other
|
|
|
|
LMU-ADEBAR EU-20221, NCT00047099
|
|
|
|
|
|
|
|
Last Modified: 12/20/2006  First Published: 2/21/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Under 80
|
|
|
|
Other
|
|
|
|
FRE-FNCLCC-GETUG-12/0203 EU-20238, NCT00055731
|
|
|
|
|
|
|
|
Last Modified: 1/14/2009  First Published: 8/24/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Active
|
|
|
|
18 to 49
|
|
|
|
NCI
|
|
|
|
SWOG-S0230 CALGB-40401, ECOG-S0230, NCT00068601, IBCSG-34-05, EUDRACT-2006-002600-33, EU-20632
|
|
|
|
|
|
|
|
Last Modified: 5/12/2008  First Published: 2/18/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
FRE-FNCLCC-GETUG-15/0403 NCT00104715
|
|
|
|
|
|
|
|
Last Modified: 1/14/2009  First Published: 1/25/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RTOG-0521 NCT00288080
|
|
|
|
|
|
|
|
Last Modified: 1/13/2009  First Published: 5/11/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RTOG-0518 0518, NCT00329797
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
2003-0819 NCT00388804
|
|
|
|
|
|
|
|
First Published: 1/5/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
FRE-FNCLCC-GETUG-16/0504 EU-20668, EUDRACT-2005-005165, NCT00423475
|
|
|
|
|
|
|
|
Last Modified: 1/14/2009  First Published: 1/25/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CALGB-90203 NCT00430183
|
|
|
|